Skip to main content
. 2000 Dec;173(6):403–407. doi: 10.1136/ewjm.173.6.403

Table 1.

Management protocols in 6 chest pain evaluation units

Study, year Duration of protocol, hr ECG Biochemical markers Additional testing
Zalenski et al,9 1997 12 0, 6, and 12 hr CK-MB at 0, 4, 8, and 12 hr Exercise tolerance testing (ETT)
Gibler et al,10 1995 9 Continuous ST segment monitor CK-MB at 0, 3, 6, and 9 hr 2-dimensional echo, ETT
Hoekstra et al,11 1994 9 Continuous ST segment monitor CK-MB at 0, 3, 6, and 9 hr Thallium ETT
Doherty et al,12 1994 9 0, 3, 6, and 9 hr CK-MB at 0, 3, 6, and 9 hr Cardiology consultation, ETT, thallium ETT, MUGA scan
Mikhail et al,13 1997 8 Continuous ST segment monitor Total CK at 0 hours; with or without CK-MB at 0, 4, and 8 hr; with or without myoglobin at 0 and 4 hr ETT, stress echo, dobutamine echo, thallium ETT
Gomez et al,14 1996 9 Continuous ST segment monitor Total CK and CK-MB at 0, 3, 6, and 9 hr ETT, dobutamine echo
ECG = electrocardiography; CK-MB = creatine kinase—muscle-brain isoenzymes; echo = echocardiography; MUGA = multigated angiocardiography.